Metastasis is a multistep process that is critically dependent on the interaction of metastasizing tumor cells with cells in the local microenvironment. Within this tumor stroma, vessel-associated pericytes and myofibroblasts share a number of traits including the upregulated expression of the transmembrane receptor endosialin (CD248). Comparative experiments in wildtype and endosialindeficient mice revealed that stromal endosialin does not affect primary tumor growth but strongly promotes spontaneous metastasis. Mechanistically, endosialin-expressing pericytes in the primary tumor facilitate distant site metastasis by promoting tumor cell intravasation in a cell contactdependent manner resulting in elevated numbers of circulating tumor cells. Corresponding to these preclinical experiments, in independent cohorts of primary human breast cancers, upregulated endosialin expression significantly correlates with increased metastasis and poorer patient survival.
INTRODUCTION
The vast majority of cancer-related mortality is due to distant site metastasis and not to primary tumor growth. Metastasis thereby marks the transition from a local to a systemic disease. The multistep nature of metastatic tumor cell dissemination and colonization is widely appreciated (1) .
Yet, the molecular and mechanistic understanding of individual steps of the metastatic cascade and the identification of bottlenecks that could serve as therapeutic targets is still in its infancy.
Metastatic progression is critically dependent on the interaction of metastasizing tumor cells with the cells of their microenvironment, both at the primary tumor site as well as at the site of metastasis (2, 3) . Among the cells of the tumor microenvironment, stromal myofibroblasts, macrophages and other inflammatory cells, as well as cellular constituents of blood and lymphatic vessels, i.e. endothelial cells, pericytes and vascular smooth muscle cells, comprise the tumor stroma (4, 5) . Interestingly, tumor-associated pericytes and stromal myofibroblasts share a number of functional and molecular traits including the expression of the cell surface receptor endosialin (CD248).
Endosialin (CD248) is a transmembrane glycoprotein (6) that was originally described as a cell surface marker of the tumor endothelium (7, 8) . However, high-resolution morphological analyses of a range of human cancers have unequivocally demonstrated that endosialin is not expressed by endothelial cells, but by pericytes and myofibroblasts (9) (10) (11) (12) (13) . Importantly, resting mesenchymal cells in the healthy adult have low or undetectable levels of endosialin expression. Expression is essentially restricted to activated cells of the mesenchymal lineage during embryogenesis (10, 14) as well as during pathological states including tumor progression and metastasis (13, 15, 16) , making endosialin an oncofetal protein with potential as a biomarker and a therapeutic target (17) (18) (19) (20) . In fact, clinical trials in solid tumors and lymphomas with an endosialin targeting antibody are ongoing (www.clinicaltrials.gov/ct2/results?term=endosialin&Search=Search) (21) .
Functionally, endosialin regulates mesenchymal cell proliferation through PDGFRβ signaling (22, 23) , which has been associated with the promigratory mesenchymal cell phenotype (24) (25) (26) .
Endosialin-deficient mice are, unless pathologically challenged, phenotypically normal (27) , although 4 they display some delay of developmental vascular remodeling caused by perturbed pericyte function (28, 29) . Earlier studies have reported no overt difference in the growth of subcutaneous tumors in wildtype and endosialin-deficient mice (27, 28, 30 ). Yet, transplantable colorectal tumors grown orthotopically in endosialin-deficient mice, displayed a prominent reduction in primary tumor growth, invasion and metastasis compared to endosialin wildtype tumor-bearing mice (27) . This striking difference between subcutaneous and orthotopic tumor growth in endosialin-deficient mice prototypically highlights the important contribution of the microenvironment to tumor progression and metastasis and identifies endosialin as a functionally relevant receptor in the tumor stroma. At the same time, pericytes have been shown to limit metastasis in the Rip1Tag2 model of pancreatic β cell tumorigenesis (31) . Conceptually linking these two totally independent lines of research, we hypothesized that the upregulated expression of endosialin by tumor-associated pericytes may be an important contributor to tumor progression and metastasis. We consequently set out to systematically dissect the role of endosialin in the control of individual steps of the metastatic cascade. These experiments yielded unexpected mechanistic insights into the role of endosialin in regulating metastasis and identified the control of tumor cell intravasation by activated pericytes as a critical and rate-limiting step.
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METHODS
In vivo studies
In vivo experiments were carried out under a UK Home Office Project license 70/7413 or under ethical guidelines of the local Animal Use and Care Committees approved by the Regierungspräsidium in Karlsruhe, Germany [35-9185.81/G-195/10] . Animals were housed in barriers at the animal facility of the DKFZ or in Optimice cages at the ICR. All animals were monitored on a daily basis for signs of ill health and had free admission to food and water. 129/Sv mice with a global knockout of endosialin were kindly provided by Dr. David Huso (Johns Hopkins Medical Institutions, Baltimore, USA) (27) . Mice were backcrossed for 6 generations with either BALB/c (Charles River), Swiss nude mice (Charles River) or C57BL/6 (DKFZ) mice. Genotypes were confirmed by PCR. For 4T1 or LLC tumor resection, primary tumors were removed under general anesthesia.
Mice with tumors not effectively removed or with subsequent tumor recurrence were removed from analyses. Mice were sacrificed at the indicated time points or when they showed signs of ill health.
Protocols for tissue processing, vascular leakage and hypoxia assessment are described in the Supplementary Data.
Ex vivo culture of circulating tumor cells
Arterial blood was isolated by cardiac puncture and 100µL plated in DMEM plus 10% FCS per 10cm tissue culture plate. Tumor cell colonies were stained 14 days later with crystal violet. Plates were scanned at 300dpi on EpsonV700 scanner and analyzed by Adobe Photoshop CS6. 
Patient samples
The German study was registered at the tissue bank of the National Center for Tumor Diseases (NCT, 
Statistical analysis
Statistics were performed using GraphPad Prism 6. Unless otherwise stated, all numerical data are expressed mean±standard error of the mean (SEM). All comparisons between 2 groups were made using the two-tailed, unpaired Student's t-test, if not indicated otherwise. Unless otherwise stated in the figure legend, *=P<0.05, **=P<0.01 and ***=P<0.001.
RESULTS
Stromal expression of endosialin does not affect primary tumor growth but promotes spontaneous metastasis
To investigate the role of stromal endosialin on tumor metastasis, we compared growth and 
Endosialin does not affect metastatic seeding or colonization
Based on the prominent metastasis phenotype in the absence of an overt primary tumor phenotype, we hypothesized that stromal endosialin might affect metastatic seeding and/or colonization.
Consequently, we studied metastatic colonization upon tail vein injection of 4T1 ( Fig. S4A and B). Consistent with the indistinguishable structural and functional vessel attributes, primary tumor hypoxia, necrosis, tumor cell proliferation or apoptosis did not differ between WT and EN KO mice in either tumor model (Fig. 4I-L, Supplementary Fig. S4C-G) . Finally, given that endosialin is also expressed by myofibroblasts, we assessed stromal collagen deposition in the primary tumors by Sirious red staining and the distribution and abundance of αSMA-positive myofibroblasts, which again showed no differences between the experimental groups (Supplementary Fig. S4H -J). Taken together, these studies revealed no discernible structural stromal differences between tumors in WT and EN KO mice that could account for the prominent metastatic phenotype of endosialin-deficient mice.
Stromal endosialin promotes tumor cell intravasation
A key role of pericytes is in stabilizing the normal vasculature (33) . Given the striking upregulation of endosialin expression on tumor-associated pericytes (9-13), we next addressed whether tumor cells displayed an altered propensity to intravasate into the vasculature in WT and EN KO mice. Consistent with the data in Figure 1 , 4T1 primary tumor growth was indistinguishable between the experimental groups, but EN KO mice showed a significant reduction of spontaneous lung metastasis as monitored by digital droplet PCR ( Fig. 5A and B) . Importantly, tumor cell colonies derived from arterial blood were significantly reduced in EN KO mice ( (Fig. 6B) . To ensure that these effects were not restricted to 10T1/2 cells, the experiment was repeated using pericytes isolated from the brains of non-tumor bearing WT and EN KO mice ( Fig. 6C and D; Supplementary Fig. S6B ). Again, the presence of WT pericytes, but not EN KO pericytes, enhanced the transmigration of co-cultured 4T1-RFP cells (Fig. 6D) .
To validate the tumor cell transmigration enhancing effect of pericyte-expressed endosialin, we examined the ability of human MDA-MB-231 breast cancer cells to transmigrate across a layer of shNT or shEN human brain pericytes ( Supplementary Fig. S6C-E) . As with the mouse cell experiments, the presence of shNT-human pericytes, but not shEN-pericytes, promoted transmigration of the cocultured human tumor cells (Fig. 6E) .
Finally, to closer model tumor cell intravasation, we mimicked the 3D assembly of the normal vessel wall by allowing tumor cells to transmigrate across sandwich-cultured HUVEC or microvascular endothelial cells and pericytes ( Supplementary Fig. S5C and D) . As in tumors (see Supplementary Fig.   S1 ) neither HUVEC (9) nor microvascular endothelial cells ( Supplementary Fig. S7A ) express endosialin. The presence of endosialin-expressing pericytes significantly promoted tumor cell transmigration across the endothelial cell monolayer (Fig. 6F) . Equivalent results were obtained using mouse microvascular endothelial cells and shEN or shNT 10T1/2 cells (Supplementary Fig. S7B ).
Notably, there was no difference between tumor cell transmigration across the endothelial monolayer in the presence of pericytes with downregulated endosialin expression and across an endothelial cell monolayer without pericytes, indicating that endosialin-expressing pericytes actively promote tumor cell intravasation into the vasculature.
Stromal cell endosialin effects on tumor cell intravasation are cell contact-dependent
To shed further insights into the mechanism by which stromal endosialin promotes tumor cell intravasation, we performed transmigration experiments in the presence of pericyte-conditioned medium ( Supplementary Fig. S5E ). The promotion of tumor cell transmigration by endosialin-13 expressing pericytes could not be recapitulated by replacing pericytes with pericyte-conditioned medium (Fig. 6G) Fig. 6H and I ).
Finally, we investigated whether a pericyte remodeled matrix could substitute for the promigratory cell-cell contact dependent phenotype observed with intact pericytes. 10T1/2 cells and isolated brain pericytes were allowed to remodel the matrix of Matrigel-coated Transwell filters, prior to decellularization by ammonium hydroxide treatment ( Supplementary Fig. S5F ). Notably, the enhanced transmigratory phenotype of 4T1-RFP cells co-cultured with live shNT pericytes was not recapitulated by a pericyte-remodeled matrix ( Supplementary Fig. S7C ). Similarly, the increased adhesion of 4T1 cells to WT pericytes was not recapitulated in an adhesion assay where WT pericytes were replaced by WT pericyte-derived extracellular matrix ( Supplementary Fig. S7D ). These data indicate that the presence of live endosialin-expressing pericytes is required to induce the promigratory, cell-cell contact dependent intravasation phenotype of tumor cells.
Endosialin expression on primary human carcinoma samples primes for metastatic spread
Based on the prominent role of stromal endosialin in mediating metastasis in preclinical mouse models, we assessed the clinical relevance of these experimental findings. First, comparison of microdissected breast tumor stroma and normal adjacent stroma displayed a significantly higher level of endosialin (CD248) mRNA in the tumor stroma (Fig. 7A) . Next, we stained human primary invasive breast cancer samples with two independent anti-endosialin monoclonal antibodies (B1/35 and FB5) (9) . As illustrated in Figure 7B , variable expression of endosialin was detected on tumor pericytes and stromal myofibroblasts. However, with the exception of a rare subset of metaplastic breast cancers, no endosialin expression was detected on tumor cells. When comparing endosialin 14 protein and CD248 mRNA levels in the primary tumor with the metastatic stage, a significant correlation was observed between endosialin protein ( Fig. 7C; Supplementary Fig. S8A ) and mRNA levels ( Fig. 7D ) with increased incidence of metastasis. In particular, higher CD248 expression in the primary tumor was found in patients with distant metastasis to the lung, liver and bone as compared to patients without detectable metastatic disease (Supplementary Fig. S8B ). Importantly, examination of CD248 expression in microdissected breast tumor stroma (34) revealed a significant association between high stromal CD248 expression and decreased recurrence-free survival (Fig. 7E) , whereas high CD248 expression in a dataset of 334 lymph-node positive breast cancers (35) was significantly associated with decreased distant metastasis-free survival (Fig. 7F) . Taken together, these data indicate that endosialin expression in the primary tumor serves as poor prognostic factor for the development of metastatic disease.
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DISCUSSION
Endosialin (CD248) is a mesenchymal cell surface receptor that is widely expressed during embryonic development and downregulated in healthy adult tissues (10, 11, 14, 25) . Endosialin may be abundantly expressed in the adult upon pathological challenge, most notably by pericytes and myofibroblasts in the tumor-associated stroma (7, 9, 11, 12, 14) as well as in fibrotic (26) Intriguingly, where it was examined, this vascular destabilization and inhibition of tumor growth, potentially enhancing tumor hypoxia and inducing tumor cell EMT, was accompanied by increased metastatic spread (31, 37, 38) . Indeed, low pericyte coverage in clinical samples is associated with poor patient prognosis (42, 43) . These findings are reminiscent of recent studies demonstrating that two independent genetic strategies to reduce myofibroblasts in the stroma of pancreatic cancers resulted in enhanced tumor aggressiveness (44, 45) . However, while genetic deletion of Shh resulted in enhanced tumor growth (45), pharmacological targeting of the Hh pathway improved drug delivery and reduced tumor invasion and metastasis (46, 47) . These contrasting data reinforce the notion that stromal effects on tumor progression and metastasis may be highly contextual and that stromal cells can play both tumor promoting and tumor suppressing roles dependent on the tumor type and location. This has led to the concept that it may be more effective to deploy strategies to (28) , no detectable loss in pericyte coverage. Similarly, there were no significant differences in vascular patency in WT and EN KO tumors as monitored by vessel perfusion, vascular leakage and levels of primary tumor hypoxia and necrosis, indicating that an inability to upregulate endosialin expression in the tumor stroma has minimal impact on vascular integrity. Importantly, in primary tumors from EN KO mice, the number or distribution of αSMA-expressing myofibroblasts was not altered suggesting that the expression of endosialin by myofibroblasts is not the driving force of tumor cell dissemination and intravasation. Consistent with this lack of stromal disruption, no differences in primary tumor growth in WT and EN KO mice were detected in the three tumor models used in this study. Previous studies also reported no differences in LLC or B16-F0 subcutaneous primary tumor growth in WT and EN KO mice (27, 28) or following intracranial inoculation of C57MG glioblastoma cells (30) . In contrast, when HCT116 colorectal tumor fragments were orthotopically grafted onto the intestinal surface, tumors in the EN KO mice were reduced in volume and showed reduced local invasion and metastasis (27) . The mechanism underlying these effects was not investigated, but the data demonstrate that stromal endosialin modulation of primary tumor growth may vary depending on the tumor site and the conditions of the microenvironment.
To relate endosialin to distinct steps of the metastatic cascade, we performed seeding and colonization experiments by intravenous injection of tumor cells. These experiments revealed unambiguously that endosialin was not involved in secondary site colonization. We therefore focused on the intravasation of cells from the primary tumor as a possible rate-limiting step of metastasis.
Indeed, while microvessel permeability were indistinguishable in primary tumors grown in WT and EN KO mice, the expression of endosialin had a pronounced effect on the ability of tumor cells to enter the systemic blood circulation. Of note, we observed in comparative studies a reduction in spontaneous metastasis in both EN KO 
